Contra-indicated in patients with a history of any of the following gold-induced disorders: anaphylactic reactions, necrotizing enterocolitis, pulmonary fibrosis, exfoliative dermatitis, bone marrow aplasia or other severe hematologic disorders.
Adverse reactions can occur months after therapy has been discontinued.
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- TRADE NAMES: Aureotan; Aurolate; Aurothio; Miocrin; Myochrysine (Merck); Myocrisin (Sanofi-Aventis); Ridaura (Prometheus); Shiosol; Solganal (Schering); Tauredon
- INDICATIONS: Rheumatoid arthritis
- SYNONYM: auranofin; aurothioglucose
- CLASS: Disease-modifying antirheumatic drug (DMARD)
- HALF-LIFE: 5 days
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
ACE inhibitors, Benazepril, Captopril, Cilazapril, Enalapril, Fosinopril, Lisinopril, Penicillamine, Phenytoin, Quinapril, Ramipril, Trandolapril
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
